Insider Transactions in Q2 2022 at Repligen Corp (RGEN)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2022
|
Manner Carrie Eglinton |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+40.88%
|
-
|
|
May 26
2022
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
534
+7.19%
|
-
|
|
May 26
2022
|
Nicolas Barthelemy |
BUY
Grant, award, or other acquisition
|
Direct |
534
+20.42%
|
-
|
|
May 26
2022
|
Karen A Dawes |
BUY
Grant, award, or other acquisition
|
Direct |
644
+0.83%
|
-
|
|
May 26
2022
|
Konstantin Konstantinov |
BUY
Grant, award, or other acquisition
|
Direct |
534
+50.0%
|
-
|
|
May 26
2022
|
Rohin Mhatre |
BUY
Grant, award, or other acquisition
|
Direct |
1,202
+42.01%
|
-
|
|
May 25
2022
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
14,715
-3.42%
|
$2,221,965
$151.1 P/Share
|
|
May 13
2022
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
712
-1.78%
|
$106,800
$150.4 P/Share
|
|
May 13
2022
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-0.97%
|
$50,250
$150.4 P/Share
|
|
May 13
2022
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
712
-3.42%
|
$106,800
$150.4 P/Share
|
|
Apr 01
2022
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-3.33%
|
$62,980
$188.02 P/Share
|